Pralmorelin

DB18252ExperimentalSmall molecule

Pralmorelin: Overview.

Formula / weight: C₄₅H₅₅N₉O₆ · 817.992 g/mol (avg)
Also known as: D-ala-3-(2-naphthyl)-d-ala-ala-trp-d-phe-lys-nh2 · D-alanyl-3-(2-naphthyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide · Growth hormone-releasing peptide 2 · L-lysinamide, d-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-
Code names: GHRP-2 · KP-102

Resolves to

Compound

Clinical / RWD

Structure

C[C@@H](N)C(=O)N[C@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O

Targets

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pralmorelin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.